Literature DB >> 28779922

A qualitative examination of physiotherapist led community-based yoga for individuals with Huntington's disease.

Elizabeth A Ulanowski1, Megan Danzl2, Victoria Schwartz2, Chelsea Reed2.   

Abstract

PURPOSE: The purpose of this study is to examine community-based yoga, led by a physiotherapist, for individuals affected by Huntington's disease (HD).
METHODS: Qualitative case study methodology was used to examine the Hatha yoga led by a certified yoga instructor who was a neurologic physiotherapist. Data collection included participant observations, semi-structured interviews with the instructor, and structured participant surveys. Data were coded and thematically analyzed. Strategies for rigor included field engagement, triangulation, member checks, and reflexivity. OUTCOMES: Five major themes emerged regarding the value and role of yoga for individuals affected by HD: [1] Emphasis on mindfulness, [2] Yoga is modifiable and accessible, [3] Precise communication, [4] Yoga fosters a sense of community, and [5] Poses tailored to HD-specific deficits.
CONCLUSIONS: Yoga led by a physiotherapist can be tailored to enable participation by those affected by HD, addresses HD-specific deficits, and promotes a sense of community to supplement traditional physiotherapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Exercise; Huntington's disease; Mindfulness; Physiotherapy; Qualitative; Yoga

Mesh:

Year:  2017        PMID: 28779922     DOI: 10.1016/j.ctcp.2017.06.002

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  2 in total

1.  A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.

Authors:  Margaret Yu; Danny Bega
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-08-26

2.  Clinical recommendations to guide physical therapy practice for Huntington disease.

Authors:  Lori Quinn; Deb Kegelmeyer; Anne Kloos; Ashwini K Rao; Monica Busse; Nora E Fritz
Journal:  Neurology       Date:  2020-01-06       Impact factor: 11.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.